ScinoPharm Taiwan Ltd
TWSE:1789
ScinoPharm Taiwan Ltd
TWSE:1789
Price:
22.7
TWD
-1.09%
Market Closed
Market Cap:
17.9B
TWD
Balance Sheet
Balance Sheet Decomposition
ScinoPharm Taiwan Ltd
ScinoPharm Taiwan Ltd
| Current Assets | 6.7B |
| Cash & Short-Term Investments | 4.2B |
| Receivables | 494.2m |
| Other Current Assets | 2B |
| Non-Current Assets | 5.3B |
| Long-Term Investments | 80.3m |
| PP&E | 4.6B |
| Intangibles | 18.3m |
| Other Non-Current Assets | 634.9m |
Balance Sheet
ScinoPharm Taiwan Ltd
ScinoPharm Taiwan Ltd
Currency: TWD
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1 928
|
2 336
|
3 707
|
3 911
|
4 203
|
3 305
|
4 055
|
4 081
|
4 295
|
3 942
|
|
| Cash |
565
|
472
|
517
|
288
|
290
|
415
|
232
|
186
|
146
|
153
|
|
| Cash Equivalents |
1 362
|
1 864
|
3 190
|
3 623
|
3 913
|
2 890
|
3 823
|
3 895
|
4 148
|
3 789
|
|
| Short-Term Investments |
0
|
284
|
0
|
0
|
179
|
172
|
34
|
51
|
51
|
0
|
|
| Total Receivables |
722
|
1 075
|
836
|
765
|
663
|
670
|
473
|
393
|
654
|
813
|
|
| Accounts Receivables |
523
|
867
|
638
|
567
|
559
|
590
|
387
|
360
|
635
|
788
|
|
| Other Receivables |
199
|
208
|
198
|
198
|
104
|
80
|
86
|
33
|
18
|
25
|
|
| Inventory |
2 449
|
2 169
|
1 830
|
1 675
|
1 364
|
1 124
|
1 246
|
1 345
|
1 189
|
1 512
|
|
| Other Current Assets |
150
|
169
|
212
|
116
|
97
|
135
|
108
|
97
|
132
|
114
|
|
| Total Current Assets |
5 250
|
6 033
|
6 585
|
6 467
|
6 506
|
5 407
|
5 916
|
5 967
|
6 320
|
6 381
|
|
| PP&E Net |
5 350
|
5 329
|
5 274
|
5 199
|
4 868
|
5 192
|
4 975
|
4 883
|
4 797
|
4 578
|
|
| PP&E Gross |
5 350
|
5 329
|
5 274
|
5 199
|
4 868
|
5 192
|
4 975
|
4 883
|
4 797
|
4 578
|
|
| Accumulated Depreciation |
3 791
|
4 195
|
4 601
|
4 987
|
5 364
|
5 664
|
5 962
|
6 277
|
6 659
|
6 999
|
|
| Intangible Assets |
24
|
23
|
24
|
23
|
17
|
14
|
9
|
9
|
10
|
19
|
|
| Long-Term Investments |
272
|
364
|
393
|
420
|
497
|
444
|
337
|
215
|
144
|
101
|
|
| Other Long-Term Assets |
476
|
473
|
506
|
592
|
675
|
617
|
610
|
617
|
640
|
643
|
|
| Total Assets |
11 372
N/A
|
12 222
+7%
|
12 783
+5%
|
12 701
-1%
|
12 563
-1%
|
11 675
-7%
|
11 847
+1%
|
11 691
-1%
|
11 911
+2%
|
11 722
-2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
55
|
92
|
71
|
92
|
91
|
102
|
161
|
71
|
126
|
102
|
|
| Accrued Liabilities |
115
|
131
|
152
|
126
|
127
|
104
|
126
|
125
|
140
|
140
|
|
| Short-Term Debt |
1 277
|
1 702
|
983
|
375
|
233
|
90
|
9
|
0
|
78
|
32
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
32
|
220
|
1 179
|
160
|
17
|
18
|
18
|
18
|
|
| Other Current Liabilities |
470
|
350
|
454
|
303
|
317
|
285
|
374
|
343
|
442
|
438
|
|
| Total Current Liabilities |
1 918
|
2 275
|
1 692
|
1 115
|
1 946
|
742
|
687
|
556
|
803
|
729
|
|
| Long-Term Debt |
0
|
0
|
771
|
1 098
|
0
|
590
|
550
|
540
|
581
|
570
|
|
| Deferred Income Tax |
3
|
3
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
70
|
86
|
92
|
71
|
79
|
82
|
81
|
83
|
77
|
56
|
|
| Total Liabilities |
1 992
N/A
|
2 365
+19%
|
2 555
+8%
|
2 284
-11%
|
2 024
-11%
|
1 415
-30%
|
1 317
-7%
|
1 180
-10%
|
1 461
+24%
|
1 357
-7%
|
|
| Equity | |||||||||||
| Common Stock |
7 030
|
7 311
|
7 603
|
7 907
|
7 907
|
7 907
|
7 907
|
7 907
|
7 907
|
7 907
|
|
| Retained Earnings |
993
|
1 212
|
1 352
|
1 243
|
1 299
|
1 126
|
1 360
|
1 370
|
1 346
|
1 348
|
|
| Additional Paid In Capital |
1 257
|
1 266
|
1 276
|
1 287
|
1 293
|
1 295
|
1 295
|
1 295
|
1 295
|
1 295
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
81
|
30
|
43
|
18
|
55
|
98
|
|
| Other Equity |
101
|
69
|
3
|
20
|
41
|
98
|
76
|
79
|
43
|
88
|
|
| Total Equity |
9 380
N/A
|
9 857
+5%
|
10 228
+4%
|
10 417
+2%
|
10 539
+1%
|
10 260
-3%
|
10 529
+3%
|
10 511
0%
|
10 450
-1%
|
10 364
-1%
|
|
| Total Liabilities & Equity |
11 372
N/A
|
12 222
+7%
|
12 783
+5%
|
12 701
-1%
|
12 563
-1%
|
11 675
-7%
|
11 847
+1%
|
11 691
-1%
|
11 911
+2%
|
11 722
-2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
791
|
791
|
760
|
791
|
791
|
791
|
791
|
791
|
791
|
791
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
